Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  BTK inhibitor CC-292
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CC-122-DLBCL-001, NCI-2013-02088, NCT02031419
Start Over